Swiss pharmaceutical company Novartis and China’s internet giant Tencent jointly announced the official launch of an online long-term disease management platform for heart patients during the ongoing China International Import Expo on Wednesday. The platform called “AI”, representing care for the heart in Chinese, covers daily health indicator monitoring and health condition assessment through voice and image recognition and interaction as well as access to personalized information, and lies inside WeChat as a mini program, the developers said. It is the country’s first of such online AI-powered platform providing disease management for heart patients, the companies claimed. Official figures showed that there are at least 10 million patients with heart diseases in China, and medical experts said that around 50 percent of the patients die within five years after being diagnosed.